TY - JOUR
T1 - Overestimation of the risk of progression to end-stage renal disease in the poor prognosis' group according to the 2002 Japanese histological classification for immunoglobulin a nephropathy
AU - Miyazaki, Yoichi
AU - Kawamura, Tetsuya
AU - Joh, Kensuke
AU - Okonogi, Hideo
AU - Koike, Kentaro
AU - Utsunomiya, Yasunori
AU - Ogura, Makoto
AU - Matsushima, Masato
AU - Yoshimura, Mitsuhiro
AU - Horikoshi, Satoshi
AU - Suzuki, Yusuke
AU - Furusu, Akira
AU - Yasuda, Takashi
AU - Shirai, Sayuri
AU - Shibata, Takanori
AU - Endoh, Masayuki
AU - Hattori, Motoshi
AU - Akioka, Yuko
AU - Katafuti, Ritsuko
AU - Hashiguchi, Akinori
AU - Kimura, Kenjiro
AU - Matsuo, Seiichi
AU - Tomino, Yasuhiko
N1 - Funding Information:
This study was supported by a Grant-in-Aid for Progressive Renal Diseases Research, from the Ministry of Health, Labour and Welfare of Japan.
PY - 2014/6
Y1 - 2014/6
N2 - Background: The current (2012) histological classification of immunoglobulin A nephropathy was established using a case-control study of 287 patients. However, the risk of progression to end-stage renal disease (ESRD) has not been validated for the previous (2002) classification. This study aimed to determine whether the previous classification could identify the risk of long-term renal outcome through re-analysis of the 2012 cohort. Methods: On the basis of the 2002 classification, namely 'good prognosis', 'relatively good prognosis', 'relatively poor prognosis', and 'poor prognosis', we examined the clinical data at the time of biopsy, the correlation between the 2002 classification and long-term renal outcomes, and a patient-by-patient correlation between the 2002 and 2012 classification systems. This was performed by analyzing samples from the 287 patients used to establish the 2012 classification. Results: The rate of decline of estimated glomerular filtration rate was greater and the odds ratio of progression to ESRD was higher in the 'poor prognosis' group. In contrast, the odds ratio for renal death was comparable between the groups described as 'relatively poor prognosis' and 'relatively good prognosis' in the 2002 classification. Many patients in the 2002 classification were classified with a lower histological grade in the current classification, but none were classified with a higher grade. Conclusions: The 2002 classification could also identify the risk of progression to ESRD. However, it was overestimated for patients in the 'poor prognosis' group in the 2002 classification, as that group included patients with milder histological damage.
AB - Background: The current (2012) histological classification of immunoglobulin A nephropathy was established using a case-control study of 287 patients. However, the risk of progression to end-stage renal disease (ESRD) has not been validated for the previous (2002) classification. This study aimed to determine whether the previous classification could identify the risk of long-term renal outcome through re-analysis of the 2012 cohort. Methods: On the basis of the 2002 classification, namely 'good prognosis', 'relatively good prognosis', 'relatively poor prognosis', and 'poor prognosis', we examined the clinical data at the time of biopsy, the correlation between the 2002 classification and long-term renal outcomes, and a patient-by-patient correlation between the 2002 and 2012 classification systems. This was performed by analyzing samples from the 287 patients used to establish the 2012 classification. Results: The rate of decline of estimated glomerular filtration rate was greater and the odds ratio of progression to ESRD was higher in the 'poor prognosis' group. In contrast, the odds ratio for renal death was comparable between the groups described as 'relatively poor prognosis' and 'relatively good prognosis' in the 2002 classification. Many patients in the 2002 classification were classified with a lower histological grade in the current classification, but none were classified with a higher grade. Conclusions: The 2002 classification could also identify the risk of progression to ESRD. However, it was overestimated for patients in the 'poor prognosis' group in the 2002 classification, as that group included patients with milder histological damage.
KW - Case-control study
KW - Current histological classification
KW - EGFR decline
KW - IgA nephropathy classification
KW - Multicenter
KW - Tuft adhesion
UR - http://www.scopus.com/inward/record.url?scp=84903374023&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84903374023&partnerID=8YFLogxK
U2 - 10.1007/s10157-013-0848-y
DO - 10.1007/s10157-013-0848-y
M3 - Article
C2 - 23933890
AN - SCOPUS:84903374023
SN - 1342-1751
VL - 18
SP - 475
EP - 480
JO - Clinical and experimental nephrology
JF - Clinical and experimental nephrology
IS - 3
ER -